cominnex_logo_final_with_tagline.jpg
UPPTHERA and ComInnex sign research collaboration for the development of novel Proteolysis-Targeting Chimera candidates
May 04, 2021 10:00 ET | Custom Chemistry Research
BUDAPEST, Hungary and SEOUL, South Korea, May 04, 2021 (GLOBE NEWSWIRE) -- UPPTHERA, a pharmaceutical venture company aiming for new drugs based on targeted protein degradation (TPD) technology and...
ComInnex Inc. gibt Z
ComInnex Inc. gibt Zertifizierung nach ISO 9001:2015 bekannt – Globales Chemiedienstleistungs- und Forschungsunternehmen unterstreicht sein Engagement, der Biowissenschaftsbranche Dienstleistungen von höchster Qualität zu liefern
October 02, 2018 10:21 ET | ComInnex Inc.
BUDAPEST (Ungarn), Oct. 02, 2018 (GLOBE NEWSWIRE) -- Heute gibt ComInnex, ein Innovator im Bereich der Konstruktion und Synthese von neuen Verbindungen und DNA-kodierten Bibliotheksbausteinen sowie...
ComInnex Inc. annonc
ComInnex Inc. annonce la certification ISO 9001:2015 – L’organisation internationale de services chimiques et de recherche renforce son engagement visant à proposer des services de la plus haute qualité à l'industrie des sciences de la vie
October 02, 2018 10:21 ET | ComInnex Inc.
BUDAPEST, Hongrie, 02 oct. 2018 (GLOBE NEWSWIRE) -- Aujourd'hui, ComInnex, innovateur dans la conception et la synthèse de nouveaux composés, les library building blocks codés par de l’ADN et...
ComInnex Inc. announ
ComInnex Inc. announces ISO 9001:2015 certification - Global chemistry service and research organization reinforces its commitment to deliver the highest quality services to the life science industry
October 01, 2018 10:34 ET | ComInnex Inc.
BUDAPEST, Hungary, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Today ComInnex, an innovator in the design and synthesis of novel compounds, DNA encoded library building blocks and provider of services for...
ComInnex - Chemistry
ComInnex - Chemistry Innovation 2017 Review
March 29, 2018 07:56 ET | ComInnex Inc.
BUDAPEST, Hungary, March 29, 2018 (GLOBE NEWSWIRE) -- ComInnex, a chemistry research company specializing in the design and synthesis of molecules for drug discovery, today announced its review of...